Characterization and structural basis of a lethal mouse-adapted SARS-CoV-2
Shihui Sun,Hongjing Gu,Lei Cao,Qi Chen,Qing Ye,Guan Yang,Rui-Ting Li,Hang Fan,Yong-Qiang Deng,Xiaopeng Song,Yini Qi,Min Li,Jun Lan,Rui Feng,Yan Guo,Na Zhu,Si Qin,Lei Wang,Yi-Fei Zhang,Chao Zhou,Lingna Zhao,Yuehong Chen,Meng Shen,Yujun Cui,Xiao Yang,Xinquan Wang,Wenjie Tan,Hui Wang,Xiangxi Wang,Cheng-Feng Qin
DOI: https://doi.org/10.1038/s41467-021-25903-x
IF: 16.6
2021-09-27
Nature Communications
Abstract:Abstract There is an urgent need for animal models to study SARS-CoV-2 pathogenicity. Here, we generate and characterize a novel mouse-adapted SARS-CoV-2 strain, MASCp36, that causes severe respiratory symptoms, and mortality. Our model exhibits age- and gender-related mortality akin to severe COVID-19. Deep sequencing identified three amino acid substitutions, N501Y, Q493H, and K417N, at the receptor binding domain (RBD) of MASCp36, during in vivo passaging. All three RBD mutations significantly enhance binding affinity to its endogenous receptor, ACE2. Cryo-electron microscopy analysis of human ACE2 (hACE2), or mouse ACE2 (mACE2), in complex with the RBD of MASCp36, at 3.1 to 3.7 Å resolution, reveals the molecular basis for the receptor-binding switch. N501Y and Q493H enhance the binding affinity to hACE2, whereas triple mutations at N501Y/Q493H/K417N decrease affinity and reduce infectivity of MASCp36. Our study provides a platform for studying SARS-CoV-2 pathogenesis, and unveils the molecular mechanism for its rapid adaptation and evolution.
multidisciplinary sciences